EWM
DGX icon

EPG Wealth Management’s Quest Diagnostics DGX Stock Holding History

EPG Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Buy
+1,042
New +$205K 0.05% 175
2020
Q2 		– Sell
-38
Closed -$3K – 279
2020
Q1 		$3K Hold
38
– – ﹤0.01% 651
2019
Q4 		$4K Buy
+38
New +$3.96K ﹤0.01% 537

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

EPG Wealth Management's DGX Position: Q2 2026 in Review

EPG Wealth Management opened a new position in Quest Diagnostics (DGX) in Q2 2026: 1,042 shares worth $221K. The stake represents 0.05% of the portfolio and ranks #175 among its holdings. This is a return to the name: EPG Wealth Management previously reported a position in DGX as recently as Q1 2020.

EPG Wealth Management first reported a position in DGX in Q4 2019 and has held it in 3 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • EPG Wealth Management held 1,042 shares of Quest Diagnostics worth $221K as of Q2 2026.
  • Quest Diagnostics was a new EPG Wealth Management position in Q2 2026.
  • Quest Diagnostics made up 0.05% of EPG Wealth Management's portfolio in Q2 2026, its #175 holding.
  • EPG Wealth Management first reported a position in Quest Diagnostics in Q4 2019 and has held it in 3 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on EPG Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.